WallStreetZenWallStreetZen

NASDAQ: HRTX
Heron Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for HRTX

Based on 1 analyst offering 12 month price targets for Heron Therapeutics Inc.
Min Forecast
$5.00+80.51%
Avg Forecast
$5.00+80.51%
Max Forecast
$5.00+80.51%

Should I buy or sell HRTX stock?

Based on 1 analyst offering ratings for Heron Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HRTX stock forecasts and price targets.

HRTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-11

1 of 1

Forecast return on equity

Is HRTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is HRTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

HRTX revenue forecast

What is HRTX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$143.3M+12.76%
Avg 2 year Forecast
$173.1M+36.25%
Avg 3 year Forecast
$207.7M+63.49%
HRTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HRTX revenue growth forecast

How is HRTX forecast to perform vs Biotechnology companies and vs the US market?
Company
17.55%
Industry
38.32%
Market
10.27%
HRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HRTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HRTX$2.77$5.00+80.51%Buy
ANNX$4.59$16.20+253.33%Strong Buy
BMEA$11.50$55.80+385.22%Buy
VYGR$7.74$20.50+164.86%Strong Buy
TRDA$12.22$21.00+71.85%Buy

Heron Therapeutics Stock Forecast FAQ

Is Heron Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HRTX) stock is to Buy HRTX stock.

Out of 1 analyst, 0 (0%) are recommending HRTX as a Strong Buy, 1 (100%) are recommending HRTX as a Buy, 0 (0%) are recommending HRTX as a Hold, 0 (0%) are recommending HRTX as a Sell, and 0 (0%) are recommending HRTX as a Strong Sell.

If you're new to stock investing, here's how to buy Heron Therapeutics stock.

What is HRTX's revenue growth forecast for 2024-2026?

(NASDAQ: HRTX) Heron Therapeutics's forecast annual revenue growth rate of 17.55% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Heron Therapeutics's revenue in 2024 is $127,044,000.On average, 2 Wall Street analysts forecast HRTX's revenue for 2024 to be $21,534,569,801, with the lowest HRTX revenue forecast at $20,745,344,730, and the highest HRTX revenue forecast at $22,323,794,873. On average, 2 Wall Street analysts forecast HRTX's revenue for 2025 to be $26,021,878,064, with the lowest HRTX revenue forecast at $25,736,253,752, and the highest HRTX revenue forecast at $26,307,502,375.

In 2026, HRTX is forecast to generate $31,223,247,105 in revenue, with the lowest revenue forecast at $31,223,247,105 and the highest revenue forecast at $31,223,247,105.

What is HRTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: HRTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is HRTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HRTX price target, the average HRTX price target is $5.00, with the highest HRTX stock price forecast at $5.00 and the lowest HRTX stock price forecast at $5.00.

The Wall Street analyst predicted that Heron Therapeutics's share price could reach $5.00 by Apr 11, 2025. The average Heron Therapeutics stock price prediction forecasts a potential upside of 80.51% from the current HRTX share price of $2.77.

What is HRTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: HRTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.